Nelson Vergel
Founder, ExcelMale.com
Study eyed zinc for slowing progression of chronic liver disease
Publish date: November 14, 2016
By: Amy Karon Frontline Medical News
Key clinical point: Oral zinc sulfate supplementation might help prevent the progression of chronic liver disease and associated hepatocellular carcinoma.
Major finding: Despite having multiple indicators of worse liver disease, only 9.5% of zinc recipients developed hepatocellular carcinoma over 3 years, compared with 25% of patients in the control group (P = .005).
Data source: A retrospective cohort study of 267 patients with chronic liver disease but no hepatocellular carcinoma at baseline.
http://www.mdedge.com/oncologypract...&utm_content=November's Top 10 News Headlines
Publish date: November 14, 2016
By: Amy Karon Frontline Medical News
Key clinical point: Oral zinc sulfate supplementation might help prevent the progression of chronic liver disease and associated hepatocellular carcinoma.
Major finding: Despite having multiple indicators of worse liver disease, only 9.5% of zinc recipients developed hepatocellular carcinoma over 3 years, compared with 25% of patients in the control group (P = .005).
Data source: A retrospective cohort study of 267 patients with chronic liver disease but no hepatocellular carcinoma at baseline.
http://www.mdedge.com/oncologypract...&utm_content=November's Top 10 News Headlines
